InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Helash Kevin, Chief Executive Officer. Director active across 2 companies, notably MARRONE BIO INNOVATIONS INC. Cumulatively, 8 filings have been recorded. Activity tracked since 26 May 2021. The latest transaction was filed on 12 July 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
Declarations8 total
241,568 shares0Common StockSEC:0001209191-22-042211:0
178,831 shares@ US$0.632124.8% of flowCommon StockSEC:0001209191-22-020079:0
178,831 shares@ US$0.632124.8% of flowCommon StockSEC:0001209191-22-008138:0
178,831 shares@ US$0.632165.9% of flowCommon StockSEC:0001209191-22-008138
47,000 shares@ US$1.069910.8% of flowCommon StockSEC:0001209191-21-053129:0
47,000 shares@ US$1.069910.8% of flowCommon StockSEC:0001209191-21-053129
6,795 shares@ US$1.472.1% of flowCommon StockSEC:0001209191-21-036194:0
6,795 shares@ US$1.472.1% of flowCommon StockSEC:0001209191-21-036194
8 of 8 declarations
About Helash Kevin
Kevin Helash is the Chief Executive Officer of Marrone Bio Innovations Inc. In this role, he is responsible for the strategic and operational leadership of the company. Kevin Helash plays a key role in developing new biological solutions and optimizing the company's performance. His expertise in biotechnology and management is essential for the success of Marrone Bio Innovations.
